Cedrus Investments' Head of Life Sciences Ms. Kimberly Nearing Presented at the Sino-American Pharmaceutical Professionals Association's 25th annual conference

2017-10-24 17:36 572

HONG KONG, Oct. 24, 2017 /PRNewswire/ -- The Managing Director and Head of Life Sciences at Cedrus Investments ("Cedrus"), Ms. Kimberly Nearing, was invited to present at the Sino-American Pharmaceutical Professionals Association's (SAPA) 25th Annual Conference held on 29th and 30th September in New Jersey, the U.S. SAPA has a 24-year tradition of promoting the advancement of pharmaceutical science and biotechnology, scientific exchange, and business cooperation between the U.S. and China. This premier industry event was attended by hundreds of venture capitalists, angel investors, executives from corporate venture funds, investment bankers as well as entrepreneurs from across the globe in the biopharmaceutical industry.

The theme of this year's conference was "Advancing Pharmaceutical and Biotechnology Development through Global Collaboration: Challenges and Opportunities." 70-plus distinguished speakers and panelists shared their insights covering the following fields in the pharma and biotech industries: R&D featuring Immuno-oncology; breakthrough therapies and their applications; IP protection, licensing, and enforcement; business development and licensing; global collaboration with outsourcing; innovation; and investments.

Ms. Nearing made a presentation on the trends in cross-border investment and collaboration during the 'Pharma Investment Forum' segment of the conference. The first half of the segment was comprised of presentations on new investment trends both in the U.S. and China. The second half segment featured a venture panel, where key issues facing investors and startups, successful cases, and tips of fundraising were shared with event participants by seasoned professionals. Fellow panelists included founders, partners, managing directors and senior officers from C-Bridge Capital Partners, Lilly Asian Ventures, Sangel Venture Capital, Qiming U.S. Healthcare Fund, Frees Fund, Yuanming Capital, China Merchants Bank Co., Ltd., New York Branch, and 6 Dimensions Capital among others.

Mr. Xiaodong Chen, Chair of China Affairs at SAPA said, "Kim's presentation was very comprehensive and enlightening.  She provided deep insights and observations about cross-border partnering and investing in the healthcare industry between the U.S. and China. We were all delighted that she could join us and share her expertise."

About Cedrus Investments

Cedrus Investments is a global boutique investment firm, specializing in Asset Management and Financial Advisory Services. Cedrus has offices in Hong Kong, Beijing, Shanghai, Jakarta and Grand Cayman.  Cedrus has extensive experience and a global network in the life sciences industry, including Australia, Asia, U.S., and Europe.

Media Enquiry:
Cedrus Investments Ltd.
Amy Sin

Logo -

Source: Cedrus Investments